loader image
Wednesday, November 19, 2025
80.7 F
McAllen
- Advertisement -

Skipped Your Mammogram Due to COVID-19? Schedule One Now

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

Cleveland Clinic – Q: You missed your regular mammogram in 2020 while quarantining due to COVID-19. How important is it to get a breast screening scheduled this year?

A: It is extremely important, and here’s why.

Regular screening mammograms are the best way to find breast cancer early. And when caught early enough, patients have that many more options for treatment and the best chance for a cure.  

- Advertisement -

A mammogram uses X-rays to look for any signs of breast cancer before symptoms (such as a lump) develop. Sometimes, mammograms will find a breast cancer months, or even years, before a patient notices any symptoms. 

It is not an understatement to say that the results of a mammogram can be life-saving. Catching cancer early and beginning treatment increases your chances of survival. It really is that simple.

Breast cancer stands as the world’s most commonly diagnosed cancer, according to the World Health Organization. The disease claimed the lives of more than 685,000 women across the globe in 2020.

In the United States, the American Cancer Society estimates that more than 280,000 women will receive a diagnosis of invasive breast cancer this year. An additional 50,000 will learn they have ductal carcinoma in situ, an early and non-invasive form of breast cancer.

- Advertisement -

Breast cancer survival rates have steadily increased in recent years largely due to earlier detection and treatment. Regular mammograms – particularly for women age 50 and older – helped drive that trend.

recent study looked at how many patients did not have their mammograms during the pandemic. This study showed a nearly 60% drop in the rate of screening mammograms. This is concerning.

It’s impossible to look at those numbers and not wonder how many women missed an opportunity for an early diagnosis.

COVID-19 certainly disrupted the screening cycle. And while a short-term delay may have little to no effect on a patient’s diagnosis and course of the disease, there’s worry that longer delays may lead to a later-stage diagnosis that requires more intense treatment.

So when should you schedule your screening mammogram?

ASAP! 

There are timing issues to consider, however, with the COVID-19 vaccine. We strongly encourage women to have their screening mammograms prior to getting the vaccine or at least four weeks after receiving their final vaccine dose.

The reason? The COVID vaccine – like other vaccines – can cause the lymph nodes under your arm to swell. This is a normal (and temporary) response to vaccination.

Swollen lymph nodes, however, also can be a sign of disease. Scheduling your mammogram around a COVID-19 vaccination will better allow a radiologist to determine the exact cause of any swelling.

But let’s get back to the central point: scheduling your mammogram. I urge anyone who has postponed visiting their healthcare provider because of COVID-19 to get back on track. Make your appointment and encourage your family and friends to do the same.      – Diagnostic Radiologist Laura Shepardson, MD

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Colorectal Cancer Screenings Remain Low For People Ages 45 To 49

UCLA research finds that fewer than 1 in 4 eligible younger adults completed colorectal cancer screenings after the United States Preventive Services Task Force (USPSTF) lowered the recommended screening age to 45 from 50.

DHR Health Encourages Early Detection with $99 Lung Cancer Screening Special Thru Dec. 31st

Lung cancer remains the leading cause of cancer death in the United States, accounting for about one in five cancer deaths nationwide. According to the American Cancer Society, an estimated 226,650 new cases of lung cancer will be diagnosed in 2025, and 124,730 people are expected to die from the disease. Each year, lung cancer claims more lives than colon, breast, and prostate cancers combined.

Aesculap Implant Systems Settles for $38.5M, Enters Non-Prosecution Deal

Medical device company Aesculap Implant Systems LLC (Aesculap), based in Center Valley, Pennsylvania, has agreed to pay $38.5 million to resolve allegations under the False Claims Act that the company sold knee replacement devices that it knew would fail prematurely at a higher than acceptable rate, resulting in false claims to Medicare and Medicaid.

‘Troopers, Toys & Teddy Bears’ Holiday Drive, Thru Dec. 21st

Mega Doctor News For millions around the world, the Christmas season is considered “the most...
- Advertisement -
×